肝细胞癌经动脉化疗栓塞:2023年韩国肝癌协会基于专家共识的实践推荐
韩国肝癌协会研究委员会召集12名介入放射学和肝病学专家,制定肝细胞癌经动脉化疗栓塞(TACE)的专家共识实践推荐,涵盖患者准备、操作技术和治疗后护理,获韩国介入放射学会认可,旨在提高疗效与安全性。
要点
- TACE是适合根治性治疗之外的肝细胞癌患者常用的非手术治疗方式。
- 共识推荐涵盖患者准备、操作技术及治疗后护理,以提升疗效与安全性。
- 推荐由韩国肝癌协会研究委员会12名专家制定,并获韩国介入放射学会认可。
核心结论
- 专家组就TACE的患者准备、操作技术和治疗后护理形成实践推荐,以增强疗效与安全性,并为TACE操作及围手术期患者管理提供方向和有用信息。
研究设计与样本
- 韩国肝癌协会研究委员会召集12名介入放射学和肝病学专家制定基于专家共识的实践推荐,推荐获韩国介入放射学会认可。
临床应用与阅片要点
- 推荐涵盖TACE患者准备、操作技术及治疗后护理,可用于规范TACE操作及围手术期患者管理。
- 推荐由韩国肝癌协会研究委员会组织12名专家制定,并获韩国介入放射学会认可,可作为实践参考。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as conventional TACE using Lipiodol in the 1980s. In the 2000s, drug-eluting beads were developed and applied clinically. Currently, TACE is a commonly used non-surgical treatment modality for patients with HCC who are unsuitable for curative treatment. Considering the vital role of TACE in the management of HCC, it is crucial to organize current knowledge and expert opinions regarding patient preparation, procedural techniques, and post-treatment care in TACE, which can enhance therapeutic efficacy and safety. A group of 12 experts in the fields of interventional radiology and hepatology, convened by the Research Committee of the Korean Liver Cancer Association (KLCA), has developed expert consensus-based practical recommendations in TACE. These recommendations have been endorsed by the Korean Society of Interventional Radiology and provide useful information and direction in performing TACE procedure as well as pre- and post-procedural patient care.
引用
- Cho Y, Choi JW, Kwon H, et al. Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Korean J Radiol. 2023. PMID: 37404104. doi:10.3348/kjr.2023.0385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。